C O Carlisi1, K Chantiluke1, L Norman1, A Christakou1, N Barrett2, V Giampietro3, M Brammer3, A Simmons3, K Rubia1. 1. Department of Child & Adolescent Psychiatry,Institute of Psychiatry, Psychology and Neuroscience,King's College,London,UK. 2. South London and Maudsley NHS Trust,London,UK. 3. Department of Neuroimaging,Institute of Psychiatry, Psychology and Neuroscience,King's College,London,UK.
Abstract
BACKGROUND:Serotonin is under-researched in attention deficit hyperactivity disorder (ADHD), despite accumulating evidence for its involvement in impulsiveness and the disorder. Serotonin further modulates temporal discounting (TD), which is typically abnormal in ADHD relative to healthy subjects, underpinned by reduced fronto-striato-limbic activation. This study tested whether a single acute dose of the selective serotonin reuptake inhibitor (SSRI) fluoxetine up-regulates and normalizes reduced fronto-striato-limbic neurofunctional activation in ADHD during TD. METHOD:Twelve boys with ADHD were scanned twice in a placebo-controlled randomized design under either fluoxetine (between 8 and 15 mg, titrated to weight) or placebo while performing an individually adjusted functional magnetic resonance imaging TD task. Twenty healthy controls were scanned once. Brain activation was compared in patients under either drug condition and compared to controls to test for normalization effects. RESULTS: Repeated-measures whole-brain analysis in patients revealed significant up-regulation with fluoxetine in a large cluster comprising right inferior frontal cortex, insula, premotor cortex and basal ganglia, which further correlated trend-wise with TD performance, which was impaired relative to controls under placebo, but normalized under fluoxetine. Fluoxetine further down-regulated default mode areas of posterior cingulate and precuneus. Comparisons between controls and patients under either drug condition revealed normalization with fluoxetine in right premotor-insular-parietal activation, which was reduced in patients under placebo. CONCLUSIONS: The findings show that a serotonin agonist up-regulates activation in typical ADHD dysfunctional areas in right inferior frontal cortex, insula and striatum as well as down-regulating default mode network regions in the context of impulsivity and TD.
RCT Entities:
BACKGROUND:Serotonin is under-researched in attention deficit hyperactivity disorder (ADHD), despite accumulating evidence for its involvement in impulsiveness and the disorder. Serotonin further modulates temporal discounting (TD), which is typically abnormal in ADHD relative to healthy subjects, underpinned by reduced fronto-striato-limbic activation. This study tested whether a single acute dose of the selective serotonin reuptake inhibitor (SSRI) fluoxetine up-regulates and normalizes reduced fronto-striato-limbic neurofunctional activation in ADHD during TD. METHOD: Twelve boys with ADHD were scanned twice in a placebo-controlled randomized design under either fluoxetine (between 8 and 15 mg, titrated to weight) or placebo while performing an individually adjusted functional magnetic resonance imaging TD task. Twenty healthy controls were scanned once. Brain activation was compared in patients under either drug condition and compared to controls to test for normalization effects. RESULTS: Repeated-measures whole-brain analysis in patients revealed significant up-regulation with fluoxetine in a large cluster comprising right inferior frontal cortex, insula, premotor cortex and basal ganglia, which further correlated trend-wise with TD performance, which was impaired relative to controls under placebo, but normalized under fluoxetine. Fluoxetine further down-regulated default mode areas of posterior cingulate and precuneus. Comparisons between controls and patients under either drug condition revealed normalization with fluoxetine in right premotor-insular-parietal activation, which was reduced in patients under placebo. CONCLUSIONS: The findings show that a serotonin agonist up-regulates activation in typical ADHD dysfunctional areas in right inferior frontal cortex, insula and striatum as well as down-regulating default mode network regions in the context of impulsivity and TD.
Authors: Mikhail N Koffarnus; Harshawardhan U Deshpande; Jonathan M Lisinski; Anders Eklund; Warren K Bickel; Stephen M LaConte Journal: Neuroimage Date: 2017-08-10 Impact factor: 6.556
Authors: R James R Blair; Johannah Bashford-Largo; Ru Zhang; Jennie Lukoff; Jamie S Elowsky; Ellen Leibenluft; Soonjo Hwang; Matthew Dobbertin; Karina S Blair Journal: J Child Adolesc Psychopharmacol Date: 2020-09-02 Impact factor: 2.576
Authors: Kristen R Hamilton; Jason F Smith; Stefanie F Gonçalves; Jazlyn A Nketia; Olivia N Tasheuras; Mark Yoon; Katya Rubia; Theresa J Chirles; Carl W Lejuez; Alexander J Shackman Journal: Neuropsychologia Date: 2020-05-11 Impact factor: 3.139
Authors: Mari S Golub; Edward P Hackett; Casey E Hogrefe; Csaba Leranth; John D Elsworth; Robert H Roth Journal: Dev Cogn Neurosci Date: 2017-05-01 Impact factor: 6.464
Authors: Luke J Norman; Christina O Carlisi; Anastasia Christakou; Clodagh M Murphy; Kaylita Chantiluke; Vincent Giampietro; Andrew Simmons; Michael Brammer; David Mataix-Cols; Katya Rubia Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2018-03-24
Authors: Christina O Carlisi; Luke Norman; Clodagh M Murphy; Anastasia Christakou; Kaylita Chantiluke; Vincent Giampietro; Andrew Simmons; Michael Brammer; Declan G Murphy; David Mataix-Cols; Katya Rubia Journal: Cereb Cortex Date: 2017-12-01 Impact factor: 5.357
Authors: C O Carlisi; L Norman; C M Murphy; A Christakou; K Chantiluke; V Giampietro; A Simmons; M Brammer; D G Murphy; D Mataix-Cols; K Rubia Journal: Psychol Med Date: 2017-04-24 Impact factor: 7.723
Authors: Luke J Norman; Christina O Carlisi; Anastasia Christakou; Kaylita Chantiluke; Clodagh Murphy; Andrew Simmons; Vincent Giampietro; Michael Brammer; David Mataix-Cols; Katya Rubia Journal: Psychiatry Res Neuroimaging Date: 2017-09-12 Impact factor: 2.376